Public Citizen Accuses Pfizer of Building ‘Paxlovid Patent Wall,’ Pfizer Pushes Back Post author:PacConAdmin Post published:February 18, 2022 Post category:Drug Industry Daily The advocacy group Public Citizen is accusing Pfizer of building a “Paxlovid patent wall.” Source: Drug Industry Daily You Might Also Like Apricus Terminates Fispemifene Clinical Program, Cuts Workforce April 6, 2016 EMA Adopts Revised Drug Development Guidelines for Two Inflammatory Diseases July 24, 2018 CRLs Stymie One Chinese Chemo Drug, Grant Another Second Chance May 2, 2022